MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ahj.2020.09.001

Медицинская библиотека · American heart journal · 2020

Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials.

Shaikh Asim, Ochani Rohan Kumar, Khan Muhammad Shahzeb, Riaz Haris, Khan Safi U, Sreenivasan Jayakumar, Mookadam Farouk, Doukky Rami, Butler Javed, Michos Erin D, Kalra Ankur, Krasuski Richard A

СтатьяОбзорПеревод пока не подготовлен

Аннотация

UNLABELLED: Cardiovascular randomized controlled trials (RCTs) typically set composite end points as the primary outcome to enhance statistical power. However, influence of individual component end points on overall composite outcomes remains understudied.

METHODS

We searched MEDLINE for RCTs published in 6 high-impact journals (The Lancet, the New England Journal of Medicine, Journal of the American Medical Association, Circulation, Journal of the American College of Cardiology and the European Heart Journal) from 2011 to 2017. Two-armed, parallel-design cardiovascular RCTs which reported composite outcomes were included. All-cause or cardiovascular mortality, myocardial infarction, heart failure, and stroke were deemed "hard" end points, whereas hospitalization, angina, and revascularization were identified as "soft" end points. Type of outcome (primary or secondary), event rates in treatment and control groups for the composite outcome and of its components according to predefined criteria.

RESULTS

Of the 45.8% (316/689) cardiovascular RCTs which used a composite outcome, 79.4% set the composite as the primary outcome. Death was the most common component (89.8%) followed by myocardial infarction (66.1%). About 80% of the trials reported complete data for each component. One hundred forty-seven trials (46.5%) incorporated a "soft" end point as part of their composite. Death contributed the least to the estimate of effects (R2 change = 0.005) of the composite, whereas revascularization contributed the most (R2 change = 0.423).

CONCLUSIONS

Cardiovascular RCTs frequently use composite end points, which include "soft" end points, as components in nearly 50% of studies. Higher event rates in composite end points may create a misleading interpretation of treatment impact due to large contributions from end points with less clinical significance.

Для цитирования: Shaikh Asim, Ochani Rohan Kumar, Khan Muhammad Shahzeb, Riaz Haris, Khan Safi U, Sreenivasan Jayakumar, Mookadam Farouk, Doukky Rami, Butler Javed, Michos Erin D, Kalra Ankur, Krasuski Richard A. Contribution of individual components to composite end points in contemporary cardiovascular randomized controlled trials.. American heart journal. 2020. DOI: 10.1016/j.ahj.2020.09.001.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.